Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. (Q40245240)
Jump to navigation
Jump to search
scientific article published on 22 September 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. |
scientific article published on 22 September 2016 |
Statements
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial (English)
Patrick Marcellin
Maria Buti
Edward Gane
Henry L Y Chan
Wan-Long Chuang
Tatjana Stepanova
Aric-Josun Hui
Young-Suk Lim
Rajiv Mehta
Harry L A Janssen
Subrat K Acharya
John F Flaherty
Benedetta Massetto
Kyungpil Kim
Anuj Gaggar
G Mani Subramanian
John G McHutchison
Calvin Q Pan
GS-US-320-0108 Investigators